Affiliations: [a] Department of Internal Diseases, Bashkir State Medical University, Ufa, Russian Federation
| [b] Department of Surgery, Bashkir State Medical University, Ufa, Russian Federation
| [c] Department of Laboratory Diagnostics, Bashkir State Medical University, Ufa, Russian Federation | [d] Department of Internal Diseases, Klinikum Gütersloh, Department of Cardiology and Electrophysiology, Gutersloch, Germany
| [e] Department of Urology, Bashkir State Medical University, Ufa, Russian Federation
Correspondence:
[*]
Corresponding author: Prof. Zagidullin Naufal Shamilevich, MD, PhD, Department of Internal Diseases, Bashkir State Medical University, Lenin Str. 3, 45000, Ufa, Russian Federation. Tel.: +79625467622, Fax: +73472265467; E-mail: [email protected].
Abstract: BACKGROUND: Contrast-induced nephropathy (CIN) is a formidable side effect of iodinated contrast medium use in subjects undergoing coronary angiogram (CAG). Remote ischemic preconditioning (RIPC) may reduce the risk of CIN. AIM: The aim of the study was to investigate the nephroprotective effects of RIPC in coronary heart disease (CHD) in patients, undergoing CAG, with mild to moderate lowered estimated glomerular filtration rate (eGFR). MATERIALS: In the randomized, blinded, sham RIPC (sRIPC) controlled study 51 patients with CHD and GFR less than 80 mL/min/m2, undergoing CAG, were investigated. The patients were randomized for RIPC (n = 26, 60.5±2.0 years) or sRIPC (n = 25, 62.96±1.7). RIPC was performed before the CAG by means of 3–5-minute cycle cuff pumped on the upper arm + 50 mm Hg above the systolic blood pressure (BP), while in sRIPC it corresponded to diastolic BP. The primary endpoint was the development of CIN and secondary – change of biomarkers (creatinine, urea, neutrophil gelatinase-associated lipocalin (NGAL), cystatin-C). RESULTS: In RIPC group, CIN occurred in 28% of cases, while in sRIPC – 3.8%. All investigated markers increased in sRIPC and declined in RIPC; the difference was significant in markers between the groups before and after CAG. CONCLUSIONS: RIPC proved nephroprotective effect in prevention of contrast-induced nephropathy in CHD subjects with mild to moderate lowered eGFR.
